Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting

Hui Liu,1 Hui Xu,1 Yunxia Jiang,1 Shengyuan Hao,1 Feirong Gong,2 Hongjie Mu,1 Ke Liu3 1School of Pharmacy, Yantai University, Yantai, People’s Republic of China; 2Key Laboratory for Ultrafine Materials of Ministry of Education, School of Materials Science and Engineering, East China Unive...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liu H, Xu H, Jiang Y, Hao S, Gong F, Mu H, Liu K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/69629d5035514a77a25c7919b6d76b16
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:69629d5035514a77a25c7919b6d76b16
record_format	dspace
spelling	oai:doaj.org-article:69629d5035514a77a25c7919b6d76b162021-12-02T02:32:06ZPreparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting1178-2013https://doaj.org/article/69629d5035514a77a25c7919b6d76b162015-10-01T00:00:00Zhttps://www.dovepress.com/preparation-characterization-in-vivo-pharmacokinetics-and-biodistribut-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Hui Liu,1 Hui Xu,1 Yunxia Jiang,1 Shengyuan Hao,1 Feirong Gong,2 Hongjie Mu,1 Ke Liu3 1School of Pharmacy, Yantai University, Yantai, People’s Republic of China; 2Key Laboratory for Ultrafine Materials of Ministry of Education, School of Materials Science and Engineering, East China University of Science and Technology, Shanghai, People’s Republic of China; 3Suzhou Nanomedicine R&D Co, Ltd, Suzhou, People’s Republic of China Abstract: Dimethoxycurcumin (DMC) is an analog of curcumin with superior efficacy in various disease models. Currently, drug delivery system research on DMC is very limited, and it has become a huge challenge to realize further developments and clinical applications. In the present study, a kind of amphiphilic block copolymer, N-t-butoxycarbonyl-phenylalanine terminated monomethoxyl poly (ethylene glycol)-b-poly (ε-caprolactone), or mPEG-PCL-Phe(Boc), was prepared from monomethoxyl poly (ethylene glycol)-b-poly (ε-caprolactone) (mPEG-PCL) with its hydroxyl terminal chemically converted into N-t-butoxycarbonyl-phenylalanine (Boc-Phe). This copolymer was determined to have a fairly low critical micelle concentration (2.56×10-3 mg/mL) and passive targeting potential to tumor tissue, and thus was applied to develop a polymeric micellar formulation of DMC for the first time. The DMC-loaded micelles prepared by thin-film hydration method had typical shell–core structure, with an average particle size of 17.9±0.4 nm and a polydispersity index of 0.045±0.011. The drug loading capacity and entrapment efficiency were 9.94%±0.15% and 97.22%±0.18%, respectively, indicating a high-affinity interaction between DMC and the copolymer. At a concentration of 2 mg/mL, the reconstituted micelle solution could be maintained for at least 10 days at room temperature, and displayed a low initial burst release followed by a sustained release in vitro. Pharmacokinetic study in rats revealed that in vivo drug exposure of DMC was significantly increased and prolonged by intravenously administering DMC-loaded micelles when compared with the same dose of free DMC dissolved in dimethyl sulfoxide. Furthermore, in vivo distribution results from tumor-bearing nude mice demonstrated that this micellar formulation significantly changed the biodistribution profile of DMC and increased drug accumulation in tumors. Therefore, the polymeric micellar formulation of DMC, based on the amphiphilic block copolymer, mPEG-PCL-Phe(Boc), could provide a desirable method for delivering DMC, especially for applications in cancer therapy. Keywords: dimethoxycurcumin, polymeric micelles, characterization, pharmacokinetic profile, biodistribution, tumor targeting Liu HXu HJiang YHao SGong FMu HLiu KDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss default, Pp 6395-6410 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Liu H Xu H Jiang Y Hao S Gong F Mu H Liu K Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting
description	Hui Liu,1 Hui Xu,1 Yunxia Jiang,1 Shengyuan Hao,1 Feirong Gong,2 Hongjie Mu,1 Ke Liu3 1School of Pharmacy, Yantai University, Yantai, People’s Republic of China; 2Key Laboratory for Ultrafine Materials of Ministry of Education, School of Materials Science and Engineering, East China University of Science and Technology, Shanghai, People’s Republic of China; 3Suzhou Nanomedicine R&D Co, Ltd, Suzhou, People’s Republic of China Abstract: Dimethoxycurcumin (DMC) is an analog of curcumin with superior efficacy in various disease models. Currently, drug delivery system research on DMC is very limited, and it has become a huge challenge to realize further developments and clinical applications. In the present study, a kind of amphiphilic block copolymer, N-t-butoxycarbonyl-phenylalanine terminated monomethoxyl poly (ethylene glycol)-b-poly (ε-caprolactone), or mPEG-PCL-Phe(Boc), was prepared from monomethoxyl poly (ethylene glycol)-b-poly (ε-caprolactone) (mPEG-PCL) with its hydroxyl terminal chemically converted into N-t-butoxycarbonyl-phenylalanine (Boc-Phe). This copolymer was determined to have a fairly low critical micelle concentration (2.56×10-3 mg/mL) and passive targeting potential to tumor tissue, and thus was applied to develop a polymeric micellar formulation of DMC for the first time. The DMC-loaded micelles prepared by thin-film hydration method had typical shell–core structure, with an average particle size of 17.9±0.4 nm and a polydispersity index of 0.045±0.011. The drug loading capacity and entrapment efficiency were 9.94%±0.15% and 97.22%±0.18%, respectively, indicating a high-affinity interaction between DMC and the copolymer. At a concentration of 2 mg/mL, the reconstituted micelle solution could be maintained for at least 10 days at room temperature, and displayed a low initial burst release followed by a sustained release in vitro. Pharmacokinetic study in rats revealed that in vivo drug exposure of DMC was significantly increased and prolonged by intravenously administering DMC-loaded micelles when compared with the same dose of free DMC dissolved in dimethyl sulfoxide. Furthermore, in vivo distribution results from tumor-bearing nude mice demonstrated that this micellar formulation significantly changed the biodistribution profile of DMC and increased drug accumulation in tumors. Therefore, the polymeric micellar formulation of DMC, based on the amphiphilic block copolymer, mPEG-PCL-Phe(Boc), could provide a desirable method for delivering DMC, especially for applications in cancer therapy. Keywords: dimethoxycurcumin, polymeric micelles, characterization, pharmacokinetic profile, biodistribution, tumor targeting
format	article
author	Liu H Xu H Jiang Y Hao S Gong F Mu H Liu K
author_facet	Liu H Xu H Jiang Y Hao S Gong F Mu H Liu K
author_sort	Liu H
title	Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting
title_short	Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting
title_full	Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting
title_fullStr	Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting
title_full_unstemmed	Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting
title_sort	preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/69629d5035514a77a25c7919b6d76b16
work_keys_str_mv	AT liuh preparationcharacterizationinvivopharmacokineticsandbiodistributionofpolymericmicellardimethoxycurcuminfortumortargeting AT xuh preparationcharacterizationinvivopharmacokineticsandbiodistributionofpolymericmicellardimethoxycurcuminfortumortargeting AT jiangy preparationcharacterizationinvivopharmacokineticsandbiodistributionofpolymericmicellardimethoxycurcuminfortumortargeting AT haos preparationcharacterizationinvivopharmacokineticsandbiodistributionofpolymericmicellardimethoxycurcuminfortumortargeting AT gongf preparationcharacterizationinvivopharmacokineticsandbiodistributionofpolymericmicellardimethoxycurcuminfortumortargeting AT muh preparationcharacterizationinvivopharmacokineticsandbiodistributionofpolymericmicellardimethoxycurcuminfortumortargeting AT liuk preparationcharacterizationinvivopharmacokineticsandbiodistributionofpolymericmicellardimethoxycurcuminfortumortargeting
_version_	1718402413085327360

Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting

Ejemplares similares